000 | 00993pam a2200349Ia 4500 | ||
---|---|---|---|
999 |
_c7396 _d7396 |
||
001 | 46315359 | ||
003 | OCoLC | ||
005 | 20170507093229.0 | ||
008 | 010214s2002 stka b 001 0 eng | ||
010 | _a2001023485 | ||
015 | _aGBA1-W8673 | ||
020 | _a0443055173 | ||
020 | _a0443055505 (International ed.) | ||
040 |
_aNLM _cNLM _dUKM |
||
042 | _apcc | ||
060 | 0 | 0 | _a2002 A-073 |
060 | 1 | 0 |
_aQV 785 _bP5366 2002 |
082 | 0 | 0 |
_a615.19 _221 |
100 | _aAulton, Michael E | ||
245 | 0 | 0 |
_aPharmaceutics : _bthe science of dosage form design / _cedited by Michael E. Aulton |
250 | _a2nd ed | ||
260 |
_aEdinburgh ; New York : _bChurchill Livingstone, _c2002 |
||
300 |
_axv, 679 p. : _bill. ; _c25 cm |
||
504 | _aIncludes bibliographical references and index | ||
650 | 2 | _aDosage Forms | |
650 | 2 | _aBiopharmaceutics | |
650 | 2 | _aDrug Design | |
650 | 0 |
_aDrugs _xDesign |
|
650 | 0 |
_aDrugs _xDosage forms |
|
650 | 0 | _aPharmaceutical technology | |
942 |
_2ddc _cBK |